• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Butorphanol and pentazocine in patients with severe postoperative pain.

作者信息

Dobkin A B, Eamkaow S, Caruso F S

出版信息

Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):547-53. doi: 10.1002/cpt1975185part1547.

DOI:10.1002/cpt1975185part1547
PMID:1102232
Abstract

Either butorphanol tartrate (1, 2, or 4 mg) or pentazocine (30 or 60 mg) was given intramuscularly (5 dose groups) to 262 patients, who were scheduled for major operations, if they had severe pain after full awakening in the recovery room, postoperatively under double-blind conditions. There were at least 50 patients in each of the five dosage groups. Pain intensity and relief were scored numerically for each treated patient at 1/2 1, 2, 3 and 4 hr, while under direct surveillance, and the patients were seen again for follow-ups during the first 24 hr postoperatively. Appreciable pain relief developed within 30 min at all dose levels, with a peak analgesic effect apparent at about 1 hr. Satisfactory relief persisted for 4 hr in the majority of patients in each group. With the lowest dose of butorphanol tartrate (1 mg), which gave good pain relief for only 2 to 4 hr, approximately 60% of the patients had to be remedicated within 4 hr. Vital signs were not appreciably affected, but the patients who received the high dose of analgesics (butorphanol tartrate 4 mg or pentazocine lactate 60 mg) were often quite drowsy. The incidence of other side effects was negligible. The relative potency assay showed that butorphanol was approximately 20 times as potent as pentazocine for up to 4 hr.

摘要

相似文献

1
Butorphanol and pentazocine in patients with severe postoperative pain.
Clin Pharmacol Ther. 1975 Nov;18(5 Pt 1):547-53. doi: 10.1002/cpt1975185part1547.
2
Butorphanol: a double-blind comparison with pentazocine in post-operative patients with moderate to severe pain.布托啡诺:与喷他佐辛用于中重度疼痛术后患者的双盲对照研究
J Int Med Res. 1976;4(4):255-64. doi: 10.1177/030006057600400408.
3
Double-blind placebo controlled oral analgesic comparison of butorphanol andpentazocine in patients with moderate to severe post-operative pain.
J Int Med Res. 1977;5(6):422-8. doi: 10.1177/030006057300100207.
4
Comparison of butorphanol and pentazocine as postoperative analgesics.布托啡诺与喷他佐辛作为术后镇痛药的比较。
South Med J. 1979 May;72(5):578-80. doi: 10.1097/00007611-197905000-00020.
5
Butorphanol and morphine: a double-blind comparison of their parenteral analgesic activity.布托啡诺与吗啡:二者胃肠外镇痛活性的双盲比较
Anesth Analg. 1976 May-Jun;55(3):394-401. doi: 10.1213/00000539-197605000-00025.
6
[Double-blind studies of Stadol (butorphanol tartrate)/pentazocine for postoperative pain (author's transl)].[酒石酸布托啡诺/喷他佐辛用于术后疼痛的双盲研究(作者译)]
Masui. 1980 Mar;29(3):237-9.
7
Analgesic evaluation of butorphanol in patients with postoperative wound pain.布托啡诺用于术后伤口疼痛患者的镇痛评估
Proc West Pharmacol Soc. 1976;19:266-72.
8
Intramuscular butorphanol and meperidine in postoperative pain.
Clin Pharmacol Ther. 1976 Sep;20(3):359-64. doi: 10.1002/cpt1976203359.
9
A comparison of buprenorphine and pentazocine for the relief of postoperative pain.丁丙诺啡与喷他佐辛用于缓解术后疼痛的比较。
S Afr Med J. 1986 Jan 4;69(1):27-8.
10
Comparison of buprenorphine, pethidine and pentazocine for the relief of pain after operation.丁丙诺啡、哌替啶和喷他佐辛用于术后止痛的比较。
Br J Anaesth. 1977 Sep;49(9):913-6. doi: 10.1093/bja/49.9.913.

引用本文的文献

1
South Korean geriatrics on Beers Criteria medications at risk of adverse drug events.韩国老年医学中使用 Beers 标准药物的患者有发生药物不良事件的风险。
PLoS One. 2018 Mar 15;13(3):e0191376. doi: 10.1371/journal.pone.0191376. eCollection 2018.
2
The absolute bioavailability of transnasal butorphanol in patients experiencing rhinitis.患有鼻炎患者经鼻布托啡诺的绝对生物利用度。
Eur J Clin Pharmacol. 1993;45(6):559-62. doi: 10.1007/BF00315315.
3
The effects of age and sex on the systemic availability and pharmacokinetics of transnasal butorphanol.
年龄和性别对经鼻丁丙诺啡全身可用性及药代动力学的影响。
Eur J Clin Pharmacol. 1994;47(1):57-60. doi: 10.1007/BF00193479.
4
Clinical pharmacokinetics of narcotic agonist-antagonist drugs.麻醉性激动剂-拮抗剂药物的临床药代动力学。
Clin Pharmacokinet. 1983 Jul-Aug;8(4):332-43. doi: 10.2165/00003088-198308040-00004.
5
Opioid agonist-antagonist drugs in acute and chronic pain states.阿片类激动剂-拮抗剂药物在急慢性疼痛状态中的应用。
Drugs. 1991 Mar;41(3):326-44. doi: 10.2165/00003495-199141030-00002.
6
Butorphanol tartrate: 2. Safety and efficacy in balanced anaesthesia.
Can Anaesth Soc J. 1976 Nov;23(6):601-8. doi: 10.1007/BF03006742.
7
Butorphanol tartrate: 1. Safety and efficacy in multidose control of postoperative pain.
Can Anaesth Soc J. 1976 Nov;23(6):596-600. doi: 10.1007/BF03006741.
8
Butorphanol: a review of its pharmacological properties and therapeutic efficacy.
Drugs. 1978 Dec;16(6):473-505. doi: 10.2165/00003495-197816060-00001.
9
Comparison of analgesia by intravenous butorphanol and meperidine in patients with post-operative pain.
Can Anaesth Soc J. 1977 Jan;24(1):90-102. doi: 10.1007/BF03006816.
10
Analgesic effectiveness of the narcotic agonist-antagonists.麻醉性激动剂-拮抗剂的镇痛效果。
Br J Clin Pharmacol. 1979;7 Suppl 3(Suppl 3):297S-308S. doi: 10.1111/j.1365-2125.1979.tb04704.x.